By tapping cloud computing power, ARUP's new "Pipey" system could eventually scale to run 10,000 samples as quickly as it runs one sample.
ARUP said it is seeing larger volumes of pathology samples, requiring more advanced and efficient workflows.
Multiple variant databases are creating competition among groups that disagree on how to advance the most scientifically robust and sustainable sharing model.
The recent failure of Bristol-Myers Squibb's lung cancer immunotherapy to meet its primary endpoint demonstrates the challenge of working with imperfect biomarkers.
The company said it will use the funds to further develop its DNA search technologies based on the Taxonomer pathogen metagenomics analysis platform.
Co-discoverers of the link between the gene EIF2AK4 and specific types of pulmonary hypertension, Intermountain and ARUP are now collaborating to offer clinical testing.
The DTWG proposal for regulating in vitro clinical tests has made it into draft legislation but it still needs support from key stakeholders in the life sciences field.
Under the partnership, the companies will help drugmakers efficiently implement complementary and companion tests through lab networks.
ARUP's database is one of many options that researchers and oncologists can use to learn about whether alterations in BRCA genes are associated with hereditary breast and ovarian cancer risk.
The group hopes its proposed regulatory framework might strike a compromise between different industry stakeholders.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.